CME Group (NASDAQ:CME) Price Target Raised to $283.00 at Piper Sandler

CME Group (NASDAQ:CME) had its price objective boosted by stock analysts at Piper Sandler from $275.00 to $283.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s price objective would suggest a potential upside of 11.02% from the stock’s current price.

CME has been the subject of several other research reports. Keefe, Bruyette & Woods boosted their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a report on Friday, February 14th. Bank of America boosted their price objective on CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Morgan Stanley upgraded shares of CME Group from an “equal weight” rating to an “overweight” rating and set a $301.00 target price on the stock in a research note on Tuesday. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Finally, Barclays raised their price objective on shares of CME Group from $263.00 to $279.00 and gave the company an “equal weight” rating in a research report on Monday. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $246.80.

CME Group Price Performance

Shares of NASDAQ:CME opened at $254.90 on Tuesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The firm has a market cap of $91.85 billion, a price-to-earnings ratio of 26.52, a price-to-earnings-growth ratio of 6.76 and a beta of 0.43. The business has a 50-day simple moving average of $252.91 and a two-hundred day simple moving average of $237.72. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $273.42.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, analysts expect that CME Group will post 10.49 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares of the company’s stock, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by insiders.

Institutional Trading of CME Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wellington Management Group LLP grew its position in CME Group by 287.2% in the 3rd quarter. Wellington Management Group LLP now owns 186,608 shares of the financial services provider’s stock valued at $41,175,000 after buying an additional 138,412 shares during the last quarter. EP Wealth Advisors LLC lifted its stake in shares of CME Group by 9.7% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,226 shares of the financial services provider’s stock worth $271,000 after acquiring an additional 108 shares during the period. M&T Bank Corp boosted its holdings in shares of CME Group by 10.3% in the third quarter. M&T Bank Corp now owns 96,069 shares of the financial services provider’s stock valued at $21,198,000 after acquiring an additional 8,968 shares in the last quarter. Vestcor Inc increased its stake in shares of CME Group by 2.8% during the third quarter. Vestcor Inc now owns 14,478 shares of the financial services provider’s stock worth $3,195,000 after acquiring an additional 399 shares during the period. Finally, Brophy Wealth Management LLC purchased a new position in CME Group during the third quarter worth about $596,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.